Management of VEGF-Targeted Therapy-Induced Hypertension

被引：0
|
作者：
Stefano Caletti
Anna Paini
Maria Antonietta Coschignano
Carolina De Ciuceis
Matteo Nardin
Roberto Zulli
Maria Lorenza Muiesan
Massimo Salvetti
Damiano Rizzoni
机构：
[1] University of Brescia,Clinica Medica, Department of Medical and Surgical Sciences
来源：
Current Hypertension Reports | 2018年 / 20卷
关键词：
VEGF; Hypertension; Vascular endothelial growth factors; Tumors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Predictive and Prognostic Clinicopathologic Factors of Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy
    Park, J. Y.
    Lee, J-L
    Ro, J. Y.
    Cho, Y. M.
    [J]. MODERN PATHOLOGY, 2013, 26 : 239A - 239A
  • [32] The effect of activation of angiogenesis pathways independent of VEGF in renal cell carcinoma on resistance to VEGF-targeted antiangiogenic therapy.
    Han, Kyung Seok
    Gust, Kilian
    Awrey, Shannon
    Raven, Peter A.
    Li, Estelle
    Fazli, Ladan
    Gleave, Martin E.
    So, Alan I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [33] VEGF-targeted cancer therapeutics - paradoxical effects in endocrine organs
    Cao, Yihai
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2014, 10 (09) : 530 - 539
  • [34] Management of cancer therapy-induced oral mucositis
    Barasch, Andrei
    Epstein, Joel B.
    [J]. DERMATOLOGIC THERAPY, 2011, 24 (04) : 424 - 431
  • [35] VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor
    Abakumov, MaximA.
    Nukolova, Natalia V.
    Sokolsky-Papkov, Marina
    Shein, Sergey A.
    Sandalova, Tatiana O.
    Vishwasrao, Hemant M.
    Grinenko, Nadezhda F.
    Gubsky, Iliya L.
    Abakumov, Artem M.
    Kabanov, Alexander V.
    Chekhonin, Vladimir P.
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (04) : 825 - 833
  • [36] Vessel co-option in colorectal cancer liver metastases mediates resistance to VEGF-targeted therapy
    Frentzas, Sophia
    Thompson, Victoria L.
    Vermeulen, Peter B.
    Foo, Shane
    Brown, Gina
    Cunningham, David
    Reynolds, Andrew R.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [37] EVEROLIMUS IN METASTATIC RENAL CANCER CARCINOMA PROGRESSED ON VEGF-TARGETED THERAPY: A SINGLE-CENTRE EXPERIENCE
    Baldazzi, Valentina
    Tassi, Renato
    Lapini, Alberto
    Caruso, Salvatore
    Cipriani, Greta
    Diacciati, Sara
    Cerullo, Carmine
    Santomaggio, Carmine
    Carini, Marco
    Mazzanti, Roberto
    [J]. ANTICANCER RESEARCH, 2010, 30 (04) : 1473 - 1473
  • [38] Cessation of VEGF-targeted therapy in patients with metastatic renal cell carcinoma (mRCC): Feasibility and clinical outcome
    Sadeghi, S.
    Albiges, L.
    Wood, L. S.
    Black, S. L.
    Gilligan, T. D.
    Dreicer, R.
    Garcia, J. A.
    Escudier, B. J.
    Rini, B. I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [39] Metastatic renal cell carcinoma (mRCC) patients (pts) with sarcomatoid features treated with VEGF-targeted therapy
    Golshayan, A. R.
    George, S.
    Heng, D. Y.
    Elson, P.
    Wood, L.
    Garcia, J. A.
    Aydin, H.
    Zhou, M.
    Bukowski, R. M.
    Rini, B. I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] VEGF-Targeted Therapy in Metastatic Renal Cell Carcinoma (Retraction of vol 10, pg 191, 2005)
    Rini, Brian
    [J]. ONCOLOGIST, 2011, 16 (10): : 1481 - 1481
12345